According to filings with the U.S. Securities and Exchange Commission, Holobiome is raising up to $9,361,054.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Phil Strandwitz played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Holobiome
Holobiome is building a platform to solve the complexities of the human gut microbiome, which is then used to deliver its potential to multiple marketplaces to improve human health. Our initial focus is on mapping and manipulating the gut-brain-axis via next generation probiotics. Our gut microbes may hold the key to overcoming some of modern medicine’s most urgent challenges. Holobiome was founded by research scientists from Northeastern University with the singular mission of unlocking that potential to improve global health. Driven by a passion for improving health and dedicated to scientific rigor, we’re translating the emerging science of the human microbiome into the next generation of probiotics and targeted solutions for whole-body health.

To learn more about Holobiome, visit http://holobiome.org/

Contact:
Phil Strandwitz, Chief Executive Officer
857-244-1633
https://www.linkedin.com/in/philipstrandwitz/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.